Not a Member?
Email this page
Send the page ""
to a friend, relative, colleague or yourself.
Separate multiple email address with a comma
We do not record any personal information entered above.
Thank you. Your email has been sent.
Zydelig (idelalisib) Tablets REMS
Goals of the Zydelig (idelalisib) Tablets REMS Program
The goal of the Zydelig REMS is to mitigate the risks of fatal and/or serious hepatotoxicity, fatal and/or serious and severe diarrhea or colitis, fatal and serious pneumonitis, and fatal and/or serious infections, and fatal and serious intestinal perforation associated with Zydelig treatment by informing prescribers of the risks of
- fatal and/or serious hepatotoxicity
- fatal and/or serious and severe diarrhea or colitis
- fatal and serious pneumonitis
- fatal and/or serious infections
- fatal and serious intestinal perforation
• Communication Plan